{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T04:37:57Z","timestamp":1794717477919,"version":"4.9.1"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"crossref","award":["INV-003970"],"award-info":[{"award-number":["INV-003970"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-025-05297-7","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T14:52:41Z","timestamp":1741099961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["In vitro and in silico evaluation of synthetic compounds derived from bi-triazoles against asexual and sexual forms of Plasmodium falciparum"],"prefix":"10.1186","volume":"24","author":[{"given":"Leandro","family":"do Nascimento Martinez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minelly Azevedo","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saara Neri","family":"Fialho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcinete Latorre","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e1lia","family":"dos Santos Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurileya","family":"de Jesus Gouveia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Welington da Silva Paula","family":"do Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula de Azevedo","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norton Rubens Diunior Lucas Pejara","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jansen Fernandes","family":"de Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie Ferreira","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quelli Larissa Oliveira","family":"de Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Roland","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina Baptista","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maisa","family":"da Silva Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Bioni Garcia","family":"Teles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"key":"5297_CR1","unstructured":"WHO. World malaria report 2023 Geneva, World Health Organization, 2023. https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2023. Accessed 16 Nov 2024."},{"key":"5297_CR2","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.pt.2020.07.004","volume":"36","author":"DS Khoury","year":"2020","unstructured":"Khoury DS, Cao P, Zaloumis SG, Davenport MP. Artemisinin resistance and the unique selection pressure of a short-acting antimalarial. Trends Parasitol. 2020;36:884\u20137.","journal-title":"Trends Parasitol"},{"key":"5297_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ijpddr.2020.12.001","volume":"15","author":"MU Ferreira","year":"2021","unstructured":"Ferreira MU, Nobrega de Sousa T, Rangel GW, Johansen IC, Corder RM, Ladeia-Andrade S, et al. Monitoring Plasmodium vivax resistance to antimalarials: persisting challenges and future directions. Int J Parasitol Drugs Drug Resist. 2021;15:9\u201324.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"5297_CR4","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1056\/NEJMc0805011","volume":"359","author":"H Noedl","year":"2008","unstructured":"Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 2008;359:2619\u201320.","journal-title":"N Engl J Med"},{"key":"5297_CR5","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/med.21486","volume":"38","author":"Poonam","year":"2018","unstructured":"Poonam, Gupta Y, Gupta N, Singh S, Wu L, Chhikara BS, et al. Multistage inhibitors of the malaria parasite: emerging hope for chemoprotection and malaria eradication. Med Res Rev. 2018;38:1511\u201335.","journal-title":"Med Res Rev"},{"key":"5297_CR6","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/imr.12817","volume":"293","author":"TM Tran","year":"2020","unstructured":"Tran TM, Crompton PD. Decoding the complexities of human malaria through systems immunology. Immunol Rev. 2020;293:144\u201362.","journal-title":"Immunol Rev"},{"key":"5297_CR7","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1038\/s41467-018-05777-2","volume":"9","author":"MJ Delves","year":"2018","unstructured":"Delves MJ, Miguel-Blanco C, Matthews H, Molina I, Ruecker A, Yahiya S, et al. A high throughput screen for next-generation leads targeting malaria parasite transmission. Nat Commun. 2018;9:3805.","journal-title":"Nat Commun"},{"key":"5297_CR8","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.pt.2016.05.010","volume":"32","author":"L Tilley","year":"2016","unstructured":"Tilley L, Straimer J, Gn\u00e4dig NF, Ralph SA, Fidock DA. Artemisinin action and resistance in Plasmodium falciparum. Trends Parasitol. 2016;32:682\u201396.","journal-title":"Trends Parasitol"},{"key":"5297_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/parasitologia2020011","volume":"2","author":"BA Munro","year":"2022","unstructured":"Munro BA, McMorran BJ. Antimalarial drug strategies to target Plasmodium gametocytes. Parasitologia. 2022;2:101\u201324.","journal-title":"Parasitologia"},{"key":"5297_CR10","first-page":"CD012242","volume":"2019","author":"C Rodrigo","year":"2019","unstructured":"Rodrigo C, Rajapakse S, Fernando SD. Primaquine and tafenoquine for preventing malaria in people travelling to or living in endemic areas. Cochrane Database Syst Rev. 2019;2019:CD012242.","journal-title":"Cochrane Database Syst Rev"},{"key":"5297_CR11","unstructured":"WHO. World malaria report\u2014Policy brief on single-dose primaquine as a gametocytocide in Plasmodium falciparum malaria. [Internet]. Geneva, World Health Organization, 2015. https:\/\/cdn.who.int\/media\/docs\/default-source\/documents\/publications\/gmp\/policy-brief-on-single-dose-primaquine-as-a-gametocytocide-in-plasmodium-falciparum-malaria.pdf?sfvrsn=cab14722_2. Accessed 8 Jan 2025."},{"key":"5297_CR12","unstructured":"WHO. World malaria report 2024. Geneva, World Health Organization, 2024. https:\/\/iris.who.int\/bitstream\/handle\/10665\/379635\/B09146-eng.pdf?sequence=1. Accessed 8 Jan 2025."},{"key":"5297_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s12936-023-04728-7","volume":"22","author":"P Looareesuwan","year":"2023","unstructured":"Looareesuwan P, Krudsood S, Lawpoolsri S, Tangpukdee N, Matsee W, Nguitragool W, et al. Gametocyte prevalence and risk factors of P. falciparum malaria patients admitted at the hospital for tropical diseases, Thailand: a 20-year retrospective study. Malar J. 2023;22:321.","journal-title":"Malar J"},{"key":"5297_CR14","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1128\/AAC.00325-13","volume":"57","author":"MJ Delves","year":"2013","unstructured":"Delves MJ, Ruecker A, Straschil U, Leli\u00e8vre J, Marques S, L\u00f3pez-Barrag\u00e1n MJ, et al. Male and female Plasmodium falciparum mature gametocytes show different responses to antimalarial drugs. Antimicrob Agents Chemother. 2013;57:3268\u201374.","journal-title":"Antimicrob Agents Chemother"},{"key":"5297_CR15","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1016\/j.bmcl.2006.02.023","volume":"16","author":"Y Xia","year":"2006","unstructured":"Xia Y, Fan Z, Yao J, Liao Q, Li W, Qu F, et al. Discovery of bitriazolyl compounds as novel antiviral candidates for combating the tobacco mosaic virus. Bioorg Med Chem Lett. 2006;16:2693\u20138.","journal-title":"Bioorg Med Chem Lett"},{"key":"5297_CR16","doi-asserted-by":"publisher","first-page":"4930","DOI":"10.1007\/s00044-013-0498-3","volume":"22","author":"S Demirci","year":"2013","unstructured":"Demirci S, Basoglu S, Bozdereci A, Demirbas N. Preparation and antimicrobial activity evaluation of some new bi- and triheterocyclic azoles. Med Chem Res. 2013;22:4930\u201345.","journal-title":"Med Chem Res"},{"key":"5297_CR17","first-page":"18","volume":"19","author":"D Addla","year":"2023","unstructured":"Addla D, Diniz C, de Larissa Oliveira Santana Q, Do Nascimento Martinez L, Latorre Almeida M, Azevedo Da Silva M, et al. Synthesis of new bi-triazoles with plasmocide action against Plasmodium falciparum. Curr Bioact Compd. 2023;19:18\u201328.","journal-title":"Curr Bioact Compd"},{"key":"5297_CR18","doi-asserted-by":"publisher","first-page":"9097","DOI":"10.1021\/acs.jmedchem.7b00487","volume":"60","author":"F Lombardo","year":"2017","unstructured":"Lombardo F, Desai PV, Arimoto R, Desino KE, Fischer H, Keefer CE, et al. In silico absorption, distribution, metabolism, excretion, and pharmacokinetics (ADME-PK): utility and best practices. An industry perspective from the international consortium for innovation through quality in pharmaceutical development. J Med Chem. 2017;60:9097\u2013113.","journal-title":"J Med Chem"},{"key":"5297_CR19","doi-asserted-by":"publisher","first-page":"15160","DOI":"10.1038\/ncomms15160","volume":"8","author":"C Miguel-Blanco","year":"2017","unstructured":"Miguel-Blanco C, Molina I, Bardera AI, D\u00edaz B, de las Heras L, Lozano S, et al. Hundreds of dual-stage antimalarial molecules discovered by a functional gametocyte screen. Nat Commun. 2017;8:15160.","journal-title":"Nat Commun"},{"key":"5297_CR20","unstructured":"Ioset J-R, Brun R, Wenzler T, Kaiser M, Yardley V. Drug screening for kinetoplastids diseases: a training manual for screening in neglected diseases. DNDi and Pan-Asian Screening Network. 2009. https:\/\/dndi.org\/scientific-articles\/2009\/drug-screening-for-kinetoplastid-diseases-a-training-manual-for-screening-in-neglected-diseases\/. Accessed 16 Nov 2024."},{"key":"5297_CR21","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7:42717.","journal-title":"Sci Rep"},{"key":"5297_CR22","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","volume":"1","author":"CA Lipinski","year":"2004","unstructured":"Lipinski CA. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol. 2004;1:337\u201341.","journal-title":"Drug Discov Today Technol"},{"key":"5297_CR23","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem. 2002;45:2615\u201323.","journal-title":"J Med Chem"},{"key":"5297_CR24","volume-title":"Drug-like properties: concepts, structure design and methods","author":"EH Kerns","year":"2008","unstructured":"Kerns EH, Di L. Lipophilicity. In: Drug-like properties: concepts, structure design and methods. 1st ed. San Diego: Elsevier; 2008.","edition":"1"},{"key":"5297_CR25","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/minf.201000118","volume":"30","author":"H Pham The","year":"2011","unstructured":"Pham The H, Gonz\u00e1lez-\u00c1lvarez I, Bermejo M, Mangas Sanjuan V, Centelles I, Garrigues TM, et al. In silico prediction of Caco-2 cell permeability by a classification QSAR approach. Mol Inform. 2011;30:376\u201385.","journal-title":"Mol Inform"},{"key":"5297_CR26","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1021\/mp100465q","volume":"8","author":"L Chen","year":"2011","unstructured":"Chen L, Li Y, Zhao Q, Peng H, Hou T. ADME evaluation in drug discovery. 10. Predictions of P-glycoprotein inhibitors using recursive partitioning and naive bayesian classification techniques. Mol Pharm. 2011;8:889\u2013900.","journal-title":"Mol Pharm"},{"key":"5297_CR27","doi-asserted-by":"publisher","first-page":"5388","DOI":"10.1016\/j.bmc.2012.03.045","volume":"20","author":"V Poongavanam","year":"2012","unstructured":"Poongavanam V, Haider N, Ecker GF. Fingerprint-based in silico models for the prediction of P-glycoprotein substrates and inhibitors. Bioorg Med Chem. 2012;20:5388\u201395.","journal-title":"Bioorg Med Chem"},{"key":"5297_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2174\/1386207321666171218121557","volume":"21","author":"R Kumar","year":"2018","unstructured":"Kumar R, Sharma A, Siddiqui MH, Tiwari RK. Prediction of drug-plasma protein binding using artificial intelligence based algorithms. Comb Chem High Throughput Screen. 2018;21:57\u201364.","journal-title":"Comb Chem High Throughput Screen"},{"key":"5297_CR29","volume-title":"The practice of medicinal chemistry","author":"FM Belpaire","year":"2003","unstructured":"Belpaire FM, Bogaert MG. The fate of xenobiotics in living organisms. In: Wermuth C, editor. The practice of medicinal chemistry. 2nd ed. Amsterdam: Elsevier Inc; 2003.","edition":"2"},{"key":"5297_CR30","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1021\/ci050135u","volume":"45","author":"H Li","year":"2005","unstructured":"Li H, Yap CW, Ung CY, Xue Y, Cao ZW, Chen YZ. Effect of selection of molecular descriptors on the prediction of blood\u2212brain barrier penetrating and nonpenetrating agents by statistical learning methods. J Chem Inf Model. 2005;45:1376\u201384.","journal-title":"J Chem Inf Model"},{"key":"5297_CR31","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.tips.2005.01.003","volume":"26","author":"MC Sanguinetti","year":"2005","unstructured":"Sanguinetti MC, Mitcheson JS. Predicting drug\u2013hERG channel interactions that cause acquired long QT syndrome. Trends Pharmacol Sci. 2005;26:119\u201324.","journal-title":"Trends Pharmacol Sci"},{"key":"5297_CR32","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/B978-012369520-8.50020-6","volume-title":"Drug-like properties: concepts, structure design and methods","author":"EH Kerns","year":"2008","unstructured":"Kerns EH, Di L. Pharmacokinetics. In: Drug-like properties: concepts, structure design and methods. 1st ed. San Diego: Elsevier; 2008. p. 228\u201341.","edition":"1"},{"key":"5297_CR33","unstructured":"GHS. Globally Harmonized System of Classification and Labelling of Chemicals (GHS). 2023; p. 1\u2013592. https:\/\/unece.org\/sites\/default\/files\/2023-07\/GHS%20Rev10e.pdf. Accessed 16 Nov 2024."},{"key":"5297_CR34","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1021\/acs.jcim.5b00238","volume":"55","author":"Y Xu","year":"2015","unstructured":"Xu Y, Dai Z, Chen F, Gao S, Pei J, Lai L. deep learning for drug-induced liver injury. J Chem Inf Model. 2015;55:2085\u201393.","journal-title":"J Chem Inf Model"},{"key":"5297_CR35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/1062936X.2011.645874","volume":"23","author":"D-S Cao","year":"2012","unstructured":"Cao D-S, Zhao J-C, Yang Y-N, Zhao C-X, Yan J, Liu S, et al. In silico toxicity prediction by support vector machine and SMILES representation-based string kernel. SAR QSAR Environ Res. 2012;23:141\u201353.","journal-title":"SAR QSAR Environ Res"},{"key":"5297_CR36","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1126\/science.781840","volume":"193","author":"W Trager","year":"1976","unstructured":"Trager W, Jensen JB. Human malaria parasites in continuous culture. Science. 1976;193:673\u20135.","journal-title":"Science"},{"key":"5297_CR37","doi-asserted-by":"publisher","first-page":"418","DOI":"10.2307\/3280287","volume":"65","author":"C Lambros","year":"1979","unstructured":"Lambros C, Vanderberg JP. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol. 1979;65:418.","journal-title":"J Parasitol"},{"key":"5297_CR38","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","volume":"48","author":"M Smilkstein","year":"2004","unstructured":"Smilkstein M, Sriwilaijaroen N, Kelly JX, Wilairat P, Riscoe M. Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob Agents Chemother. 2004;48:1803\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"5297_CR39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00436-010-2034-4","volume":"108","author":"A Bagavan","year":"2011","unstructured":"Bagavan A, Rahuman AA, Kaushik NK, Sahal D. In vitro antimalarial activity of medicinal plant extracts against Plasmodium falciparum. Parasitol Res. 2011;108:15\u201322.","journal-title":"Parasitol Res"},{"key":"5297_CR40","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jep.2006.04.003","volume":"106","author":"P Cos","year":"2006","unstructured":"Cos P, Vlietinck AJ, Berghe DV, Maes L. Anti-infective potential of natural products: how to develop a stronger in vitro \u2018proof-of-concept. J Ethnopharmacol. 2006;106:290\u2013302.","journal-title":"J Ethnopharmacol"},{"key":"5297_CR41","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1006\/expr.1994.1098","volume":"79","author":"JM Calvo-Calle","year":"1994","unstructured":"Calvo-Calle JM, Moreno A, Eling WMC, Nardin EH. In vitro development of infectious liver stages of P. yoelii and P. berghei malaria in human cell lines. Exp Parasitol. 1994;79:362\u201373.","journal-title":"Exp Parasitol"},{"key":"5297_CR42","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55\u201363.","journal-title":"J Immunol Methods"},{"key":"5297_CR43","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.bbrc.2010.10.108","volume":"402","author":"C Wang","year":"2010","unstructured":"Wang C, Qin X, Huang B, He F, Zeng C. Hemolysis of human erythrocytes induced by melamine\u2013cyanurate complex. Biochem Biophys Res Commun. 2010;402:773\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"5297_CR44","first-page":"109","volume":"1","author":"F Nogueira","year":"2010","unstructured":"Nogueira F, do Ros\u00e1rio VE. Methods for assessment of antimalarial activity in the different phases of the Plasmodium life cycle. Rev Panamazonica Saude. 2010;1:109\u201324.","journal-title":"Rev Panamazonica Saude"},{"key":"5297_CR45","doi-asserted-by":"publisher","first-page":"492","DOI":"10.5935\/0100-4042.20140075","volume":"37","author":"PR Gomes","year":"2014","unstructured":"Gomes PR, Miguel FB, de Oliveira M\u00c9, Ferreira VV, Guimar\u00e3es DSM, de Lima AB, et al. Synthesis and evaluation of antimalarial activity of curcumin derivatives. Quim Nova. 2014;37:492\u20136.","journal-title":"Quim Nova"},{"key":"5297_CR46","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nrd4683","volume":"14","author":"K Katsuno","year":"2015","unstructured":"Katsuno K, Burrows JN, Duncan K, van Huijsduijnen RH, Kaneko T, Kita K, et al. Hit and lead criteria in drug discovery for infectious diseases of the developing world. Nat Rev Drug Discov. 2015;14:751\u20138.","journal-title":"Nat Rev Drug Discov"},{"key":"5297_CR47","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1038\/nprot.2016.096","volume":"11","author":"MJ Delves","year":"2016","unstructured":"Delves MJ, Straschil U, Ruecker A, Miguel-Blanco C, Marques S, Dufour AC, et al. Routine in vitro culture of P. falciparum gametocytes to evaluate novel transmission-blocking interventions. Nat Protoc. 2016;11:1668\u201380.","journal-title":"Nat Protoc"},{"key":"5297_CR48","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1186\/1475-2875-12-408","volume":"12","author":"S Duffy","year":"2013","unstructured":"Duffy S, Avery VM. Identification of inhibitors of Plasmodium falciparum gametocyte development. Malar J. 2013;12:408.","journal-title":"Malar J"},{"key":"5297_CR49","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.exppara.2013.09.010","volume":"135","author":"J Miao","year":"2013","unstructured":"Miao J, Wang Z, Liu M, Parker D, Li X, Chen X, et al. Plasmodium falciparum: generation of pure gametocyte culture by heparin treatment. Exp Parasitol. 2013;135:541\u20135.","journal-title":"Exp Parasitol"},{"key":"5297_CR50","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12936-015-0752-x","volume":"14","author":"L-J Leba","year":"2015","unstructured":"Leba L-J, Musset L, Pelleau S, Estevez Y, Birer C, Briolant S, et al. Use of Plasmodium falciparum culture-adapted field isolates for in vitro exflagellation-blocking assay. Malar J. 2015;14:234.","journal-title":"Malar J"},{"key":"5297_CR51","doi-asserted-by":"publisher","first-page":"7764","DOI":"10.1038\/s41598-018-26125-w","volume":"8","author":"G Colmenarejo","year":"2018","unstructured":"Colmenarejo G, Lozano S, Gonz\u00e1lez-Cort\u00e9s C, Calvo D, Sanchez-Garcia J, Matilla J-LP, et al. Predicting transmission blocking potential of anti-malarial compounds in the mosquito feeding assay using Plasmodium falciparum male gamete inhibition assay. Sci Rep. 2018;8:7764.","journal-title":"Sci Rep"},{"key":"5297_CR52","unstructured":"Magalh\u00e3es U de O. Modelagem molecular e avalia\u00e7\u00e3o da rela\u00e7\u00e3o estruturaatividade acoplados a estudos f\u00edsico-qu\u00edmicos, farmacocin\u00e9ticos e toxicol\u00f3gicos In silico de derivados heteroc\u00edclicos com atividade leishmanicida. Dissertation, Federal University of Rio de Janeiro. 2009. https:\/\/ddec1-0-en-ctp.trendmicro.com:443\/wis\/clicktime\/v1\/query?url=http%3a%2f%2fobjdig.ufrj.br%2f59%2fteses%2f725703.pdf&umid=6b3db0f3-d9e8-4a79-b434-6ada4b9219e7&auth=1bcda6227c1853a98db9a85322c3ec3db27ad845-84d8fdb12cf65ba1865f094d7086d073dc16c488. Accessed 16 Nov 2024."},{"key":"5297_CR53","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41467-020-20629-8","volume":"12","author":"J Reader","year":"2021","unstructured":"Reader J, van der Watt ME, Taylor D, Le Manach C, Mittal N, Ottilie S, et al. Multistage and transmission-blocking targeted antimalarials discovered from the open-source MMV Pandemic Response Box. Nat Commun. 2021;12:269.","journal-title":"Nat Commun"},{"key":"5297_CR54","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.bioorg.2017.01.010","volume":"71","author":"D Dheer","year":"2017","unstructured":"Dheer D, Singh V, Shankar R. Medicinal attributes of 1,2,3-triazoles: Current developments. Bioorg Chem. 2017;71:30\u201354.","journal-title":"Bioorg Chem"},{"key":"5297_CR55","doi-asserted-by":"publisher","first-page":"7742","DOI":"10.1016\/j.bmc.2013.10.017","volume":"21","author":"J Liu","year":"2013","unstructured":"Liu J, Liu Q, Yang X, Xu S, Zhang H, Bai R, et al. Design, synthesis, and biological evaluation of 1,2,4-triazole bearing 5-substituted biphenyl-2-sulfonamide derivatives as potential antihypertensive candidates. Bioorg Med Chem. 2013;21:7742\u201351.","journal-title":"Bioorg Med Chem"},{"key":"5297_CR56","doi-asserted-by":"publisher","first-page":"723991","DOI":"10.3389\/fitd.2021.723991","volume":"2","author":"H Hamim","year":"2021","unstructured":"Hamim H, Sangeda RZ, Bundala M, Mkumbwa S, Bitegeko A, Sillo HB, et al. Utilization trends of antiviral and antifungal agents for human systemic use in Tanzania from 2010 to 2017 using the World Health Organization Collaborating Centre for Drug Statistics Methodology. Front Trop Dis. 2021;2:723991.","journal-title":"Front Trop Dis"},{"key":"5297_CR57","doi-asserted-by":"publisher","first-page":"660424","DOI":"10.3389\/fchem.2021.660424","volume":"9","author":"R Ibba","year":"2021","unstructured":"Ibba R, Piras S, Corona P, Riu F, Loddo R, Delogu I, et al. Synthesis, antitumor and antiviral in vitro activities of new benzotriazole-dicarboxamide derivatives. Front Chem. 2021;9:660424.","journal-title":"Front Chem"},{"key":"5297_CR58","volume-title":"Goodman and Gilman\u2019s: pharmacological basis of therapeutics","author":"LS Goodman","year":"1991","unstructured":"Goodman LS, Gilman AG. Goodman and Gilman\u2019s: pharmacological basis of therapeutics. 8th ed. New York: Mcgraw-Hill; 1991.","edition":"8"},{"issue":"24","key":"5297_CR59","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.3390\/molecules24213917","volume":"2019","author":"S Oramas-Royo","year":"2019","unstructured":"Oramas-Royo S, L\u00f3pez-Rojas P, Amesty A, Guti\u00e9rrez D, Flores N, Mart\u00edn-Rodr\u00edguez P, et al. Synthesis and antiplasmodial activity of 1,2,3-triazole-naphthoquinone conjugates. Molecules. 2019;2019(24):3917.","journal-title":"Molecules"},{"key":"5297_CR60","doi-asserted-by":"publisher","first-page":"115400","DOI":"10.1016\/j.ejmech.2023.115400","volume":"255","author":"RM Costa Souza","year":"2023","unstructured":"Costa Souza RM, Montenegro Pimentel LML, Ferreira LKM, Pereira VRA, Santos ACDS, Dantas WM, et al. Biological activity of 1,2,3-triazole-2-amino-1,4-naphthoquinone derivatives and their evaluation as therapeutic strategy for malaria control. Eur J Med Chem. 2023;255:115400.","journal-title":"Eur J Med Chem"},{"key":"5297_CR61","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/B978-0-12-417205-0.00013-4","volume-title":"The practice of medicinal chemistry","author":"P Bazzini","year":"2008","unstructured":"Bazzini P, Wermuth CG. Substituent groups. In: Wermuth CG, Aldous D, Raboisson P, Rognan D, editors. The practice of medicinal chemistry. 4th ed. San Diego: Elsevier; 2008. p. 319\u201357.","edition":"4"},{"key":"5297_CR62","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1021\/cr200060g","volume":"111","author":"EJ Barreiro","year":"2011","unstructured":"Barreiro EJ, K\u00fcmmerle AE, Fraga CAM. The methylation effect in medicinal chemistry. Chem Rev. 2011;111:5215\u201346.","journal-title":"Chem Rev"},{"key":"5297_CR63","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/cmdc.201200585","volume":"8","author":"C Ballatore","year":"2013","unstructured":"Ballatore C, Huryn DM, Smith AB. Carboxylic acid (Bio)isosteres in drug design. ChemMedChem. 2013;8:385\u201395.","journal-title":"ChemMedChem"},{"key":"5297_CR64","doi-asserted-by":"publisher","first-page":"8315","DOI":"10.1021\/acs.jmedchem.5b00258","volume":"58","author":"EP Gillis","year":"2015","unstructured":"Gillis EP, Eastman KJ, Hill MD, Donnelly DJ, Meanwell NA. Applications of fluorine in medicinal chemistry. J Med Chem. 2015;58:8315\u201359.","journal-title":"J Med Chem"},{"key":"5297_CR65","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/cbic.200301023","volume":"5","author":"H-J B\u00f6hm","year":"2004","unstructured":"B\u00f6hm H-J, Banner D, Bendels S, Kansy M, Kuhn B, M\u00fcller K, et al. Fluorine in medicinal chemistry. ChemBioChem. 2004;5:637\u201343.","journal-title":"ChemBioChem"},{"key":"5297_CR66","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1146\/annurev.pharmtox.41.1.443","volume":"41","author":"BK Park","year":"2001","unstructured":"Park BK, Kitteringham NR, O\u2019Neill PM. Metabolism of fluorine-containing drugs. Annu Rev Pharmacol Toxicol. 2001;41:443\u201370.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"5297_CR67","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/B978-012369520-8.50015-2","volume-title":"Drug-like properties: concepts, structure design and methods","author":"EH Kerns","year":"2008","unstructured":"Kerns EH, Di L. Plasma protein binding. In: Drug-like properties: concepts, structure design and methods. 1st ed. San Diego: Elsevier; 2008. p. 187\u201396.","edition":"1"},{"key":"5297_CR68","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12936-019-2724-z","volume":"18","author":"EG Tse","year":"2019","unstructured":"Tse EG, Korsik M, Todd MH. The past, present and future of anti-malarial medicines. Malar J. 2019;18:93.","journal-title":"Malar J"},{"key":"5297_CR69","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1021\/mp500783g","volume":"12","author":"CM Hosey","year":"2015","unstructured":"Hosey CM, Benet LZ. Predicting the extent of metabolism using in vitro permeability rate measurements and in silico permeability rate predictions. Mol Pharm. 2015;12:1456\u201366.","journal-title":"Mol Pharm"},{"key":"5297_CR70","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1023\/A:1012102522787","volume":"14","author":"S Yee","year":"1997","unstructured":"Yee S. In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man\u2014Factor or myth. Pharm Res. 1997;14:4.","journal-title":"Pharm Res"},{"key":"5297_CR71","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/bjaceaccp\/mkl058","volume":"7","author":"F Roberts","year":"2007","unstructured":"Roberts F, Freshwater-Turner D. Pharmacokinetics and anaesthesia. Continuing Educ Anaesth Crit Care Pain. 2007;7:25\u20139.","journal-title":"Continuing Educ Anaesth Crit Care Pain"},{"key":"5297_CR72","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1208\/s12248-014-9691-7","volume":"17","author":"L Di","year":"2015","unstructured":"Di L, Obach RS. Addressing the challenges of low clearance in drug research. AAPS J. 2015;17:352\u20137.","journal-title":"AAPS J"},{"key":"5297_CR73","doi-asserted-by":"publisher","first-page":"152","DOI":"10.5694\/mja2.50474","volume":"212","author":"RJ Commons","year":"2020","unstructured":"Commons RJ, McCarthy JS, Price RN. Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency. Med J Aust. 2020;212:152.","journal-title":"Med J Aust"},{"key":"5297_CR74","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/jps.2600680948","volume":"68","author":"S \u00d8ie","year":"1979","unstructured":"\u00d8ie S, Tozer TN. Effect of altered plasma protein binding on apparent volume of distribution. J Pharm Sci. 1979;68:1203\u20135.","journal-title":"J Pharm Sci"},{"key":"5297_CR75","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/cmdc.201700582","volume":"13","author":"L Sun","year":"2018","unstructured":"Sun L, Yang H, Li J, Wang T, Li W, Liu G, et al. In silico prediction of compounds binding to human plasma proteins by QSAR models. ChemMedChem. 2018;13:572\u201381.","journal-title":"ChemMedChem"},{"key":"5297_CR76","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/jps.2600690437","volume":"69","author":"G Levy","year":"1980","unstructured":"Levy G. Effect of plasma protein binding on renal clearance of drugs. J Pharm Sci. 1980;69:482\u20133.","journal-title":"J Pharm Sci"},{"key":"5297_CR77","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12936-020-03280-y","volume":"19","author":"N Pornputtapong","year":"2020","unstructured":"Pornputtapong N, Suriyapakorn B, Satayamapakorn A, Larpadisorn K, Janviriyakul P, Khemawoot P. In silico analysis for factors affecting anti-malarial penetration into red blood cells. Malar J. 2020;19:215.","journal-title":"Malar J"},{"key":"5297_CR78","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4269\/ajtmh.1997.56.17","volume":"56","author":"A Benakis","year":"1997","unstructured":"Benakis A, Paris M, Loutan L, Plessas CT, Plessas ST. Pharmacokinetics of artemisinin and artesunate after oral administration in healthy volunteers. Am J Trop Med Hyg. 1997;56:17\u201323.","journal-title":"Am J Trop Med Hyg"},{"key":"5297_CR79","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2217\/14622416.9.1.105","volume":"9","author":"FJ Sharom","year":"2008","unstructured":"Sharom FJ. ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics. 2008;9:105\u201327.","journal-title":"Pharmacogenomics"},{"key":"5297_CR80","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1080\/00498250701867889","volume":"38","author":"S-F Zhou","year":"2008","unstructured":"Zhou S-F. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica. 2008;38:802\u201332.","journal-title":"Xenobiotica"},{"key":"5297_CR81","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1590\/S0100-40422010001000027","volume":"33","author":"PC Huber","year":"2010","unstructured":"Huber PC, Maruiama CH, Almeida WP. Glicoprote\u00edna-P, resist\u00eancia a m\u00faltiplas drogas (MDR) e rela\u00e7\u00e3o estrutura-atividade de moduladores. Quim Nova. 2010;33:2148\u201354.","journal-title":"Quim Nova"},{"key":"5297_CR82","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1093\/jnci\/92.16.1295","volume":"92","author":"P Borst","year":"2000","unstructured":"Borst P, Evers R, Kool M, Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst. 2000;92:1295\u2013302.","journal-title":"J Natl Cancer Inst"},{"key":"5297_CR83","doi-asserted-by":"publisher","first-page":"137","DOI":"10.18773\/austprescr.2014.050","volume":"37","author":"A Finch","year":"2014","unstructured":"Finch A, Pillans P. P-glycoprotein and its role in drug-drug interactions. Aust Prescr. 2014;37:137\u20139.","journal-title":"Aust Prescr"},{"key":"5297_CR84","doi-asserted-by":"publisher","first-page":"8802","DOI":"10.1038\/s41598-019-44773-4","volume":"9","author":"R Miao","year":"2019","unstructured":"Miao R, Xia L-Y, Chen H-H, Huang H-H, Liang Y. Improved classification of blood-brain-barrier drugs using deep learning. Sci Rep. 2019;9:8802.","journal-title":"Sci Rep"},{"key":"5297_CR85","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.pt.2019.04.010","volume":"35","author":"G Nishanth","year":"2019","unstructured":"Nishanth G, Schl\u00fcter D. Blood\u2013brain barrier in cerebral malaria: pathogenesis and therapeutic intervention. Trends Parasitol. 2019;35:516\u201328.","journal-title":"Trends Parasitol"},{"key":"5297_CR86","doi-asserted-by":"publisher","first-page":"2","DOI":"10.12701\/yujm.2019.00297","volume":"37","author":"JI Suh","year":"2020","unstructured":"Suh JI. Drug-induced liver injury. Yeungnam Univ J Med. 2020;37:2\u201312.","journal-title":"Yeungnam Univ J Med"},{"key":"5297_CR87","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1053\/j.gastro.2008.09.011","volume":"135","author":"N Chalasani","year":"2008","unstructured":"Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology. 2008;135:1924\u201334.","journal-title":"Gastroenterology"},{"key":"5297_CR88","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1007\/s11095-008-9787-9","volume":"25","author":"S Sahin","year":"2008","unstructured":"Sahin S, Benet LZ. The operational multiple dosing half-life: a key to defining drug accumulation in patients and to designing extended release dosage forms. Pharm Res. 2008;25:2869\u201377.","journal-title":"Pharm Res"},{"key":"5297_CR89","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1021\/acs.jmedchem.7b00969","volume":"61","author":"DA Smith","year":"2018","unstructured":"Smith DA, Beaumont K, Maurer TS, Di L. Relevance of half-life in drug design. J Med Chem. 2018;61:4273\u201382.","journal-title":"J Med Chem"},{"key":"5297_CR90","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/B978-012744481-9\/50036-2","volume-title":"The practice of medicinal chemistry","author":"AC Macherey","year":"2003","unstructured":"Macherey AC, Dansette PM. Chemical mechanisms of toxicity: basic knowledge for designing safer drugs. In: The practice of medicinal chemistry. 2nd ed. Amsterdam: Elsevier; 2003. p. 545\u201360.","edition":"2"},{"key":"5297_CR91","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/B978-012369520-8.50016-4","volume-title":"Drug-like properties: concepts, structure design and methods San Diego","author":"EH Kerns","year":"2008","unstructured":"Kerns EH, Di L. Cytochrome P450 inhibition. In: Drug-like properties: concepts, structure design and methods San Diego. Amsterdam: Elsevier; 2008. p. 197\u2013208."},{"key":"5297_CR92","doi-asserted-by":"publisher","first-page":"102","DOI":"10.4103\/0019-5359.30351","volume":"61","author":"B Kalra","year":"2007","unstructured":"Kalra B. Cytochrome P450 enzyme isoforms and their therapeutic implications: an update. Indian J Med Sci. 2007;61:102.","journal-title":"Indian J Med Sci"},{"key":"5297_CR93","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.2174\/092986712801323180","volume":"19","author":"S Kumar","year":"2012","unstructured":"Kumar S, Sharma R, Roychowdhury A. Modulation of cytochrome-P450 inhibition (CYP) in drug discovery: a medicinal chemistry perspective. Curr Med Chem. 2012;19:3605\u201321.","journal-title":"Curr Med Chem"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05297-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05297-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05297-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T15:00:11Z","timestamp":1741100411000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-025-05297-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5297"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05297-7","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"11 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee for Research with Human Beings\u2014(CEP)\u2014CAAE: 56853922.2.0000.5300\u2014UNIR.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"74"}}